- Home
- DNA
as 07-26-2024 4:00pm EST
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 1.2B | IPO Year: | N/A |
| Target Price: | $1.40 | AVG Volume (30 days): | 58.7M |
| Analyst Decision: | Sell | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.26 - $2.52 | Next Earning Date: | 08-07-2024 |
| Revenue: | $208,697,000 | Revenue Growth: | -46.49% |
| Revenue Growth (this year): | -27.44% | Revenue Growth (next year): | 22.71% |
Latest Ginkgo Bioworks Holdings Inc. News
DNA Breaking Stock News: Dive into DNA Ticker-Specific Updates for Smart Investing
PR Newswire
11 days ago
Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicals
The Telegraph
2 months ago
Italian energy company targets Britain for fleet of 20 mini-nukes
Motley Fool
2 months ago
4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
AFP
2 months ago
Seoul resumes loudspeaker propaganda against North
Simply Wall St.
2 months ago
Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss
Simply Wall St.
2 months ago
American Software Full Year 2024 Earnings: EPS Beats Expectations
Simply Wall St.
2 months ago
Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns
Simply Wall St.
2 months ago
Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Compare DNA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DNA Ginkgo Bioworks Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.